| Research article - (2026)25, 675 - 690 DOI: https://doi.org/10.52082/jssm.2026.675 |
| Contrast Heat–Cold Versus Thermoneutral Showering in Trained Combat Sport Athletes: A Randomized Field Trial of Recovery Outcomes |
Magdalena Hagner-Derengowska1, , Robert Trybulski2,3, Joanna Kruk4, Filipe Manuel Clemente5,6,7, Cyprian Olchowy8, Karol Pilis9 |
| Key words: Recovery, combat sports, heart rate variability, post-occlusive reactive hyperemia |
| Key Points |
|
|
|
| Study design and setting |
This study was a randomized, field-based, parallel-group trial conducted under real-world training conditions in trained combat sport athletes recruited from two clubs located in Cieszyn and Żory, Poland. The trial was prospectively registered at ISRCTN (ISRCTN49499065) on 23 June 2025, before recruitment of the first participant, as part of a broader randomized controlled research programme evaluating different recovery strategies in physically active individuals. Ethical approval was granted by the Ethics Committee for Scientific Research of Physiotherapists of the Polish Physiotherapy Association (Resolution No. 1.06.2025, approved on 11 June 2025). All procedures were conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent before enrolment after receiving detailed information about the study procedures. Recruitment was conducted between 22 September 2025 and 20 October 2025. Baseline assessments were performed immediately after enrolment between 22 September and 24 October 2025. Each participant subsequently completed a 4-week intervention followed by a 2-week wash-out period. Final follow-up assessments were completed on 5 December 2025. The control condition consisted of thermoneutral showering and should therefore be interpreted as an active comparator rather than a no-treatment control. Consequently, the study does not estimate the absolute efficacy of contrast heat-cold showering versus no intervention, but rather its relative effect compared with an equivalent-duration thermoneutral shower routine. All physiological and subjective assessments were performed at the same external medical facility (Provita Medical Center, Żory) under standardized clinical conditions to minimize site-related variability in measurement procedures. The experimental period consisted of a 4-week intervention followed by a 2-week wash-out period to evaluate persistence or reversibility of effects after cessation of the recovery protocol, with measurements at three predefined time points: baseline (T0), immediately post-intervention (T1), and post wash-out (T2). |
| Participants and eligibility criteria |
A convenience sampling approach was used, recruiting athletes from local combat-sport academies/gyms and training centers through direct contact with coaches, on-site announcements, and study flyers/shared posts on academy communication channels. Because recruitment was conducted through open club announcements, coach-mediated invitations, and shared academy communication channels, the total number of athletes exposed to recruitment materials could not be precisely enumerated. Sixty athletes formally contacted the research team, underwent eligibility screening, met the inclusion criteria, provided written informed consent, and were randomized. No athlete was excluded at formal screening. Reasons for non-participation among athletes who may have seen recruitment materials but did not contact the research team were not recorded. Interested athletes completed an eligibility screening (training history, health status, and medication use) and, if eligible, provided written informed consent before enrollment. Sixty combat sport athletes (49 men, 11 women) were recruited. Athletes were actively training throughout the study and represented Brazilian jiu-jitsu (n = 18), kickboxing (n = 15), karate (n = 14), and mixed martial arts (n = 13), with at least 3 years of continuous training experience and a minimum habitual training frequency of three sessions per week. Participants were classified as Tier 3-4 athletes (trained to highly trained) according to the McKay Framework (McKay et al., Inclusion criteria were age ≥ 18 years and the absence of acute musculoskeletal injury at enrollment. Exclusion criteria included known cardiovascular, neurological, or metabolic disorders and the use of medications likely to influence autonomic regulation or vascular function, in order to reduce confounding of HRV and microvascular endpoints. |
| Sample size planning |
An a priori sample size was determined to ensure adequate power to detect the primary longitudinal treatment effect, defined as the between-group difference in change (ΔΔ) corresponding to the Group×Time interaction in the planned longitudinal models. The sample-size calculation was anchored to lnRMSSD, which was selected as the primary outcome for sample-size planning because it represents a vagally mediated HRV index, is commonly used in applied athlete recovery monitoring, and was expected to be more responsive to short-term recovery-state modulation than morning cortisol or PORH-derived cutaneous microvascular outcomes. For planning, the primary power-driving contrast was the between-group ΔΔ in lnRMSSD from baseline to post-intervention (T1-T0). The T2-T0 contrast was retained as the planned persistence contrast, but the sample-size calculation was based on detecting the post-intervention lnRMSSD effect. We used a conservative change-score framework, with two-sided α = 0.025 to account for the two planned temporal contrasts (T1-T0 and T2-T0) and 80% power. The smallest effect considered practically relevant was set to a moderate standardized ΔΔ of d = 0.60, defined as the between-group difference in lnRMSSD change standardized by the pooled baseline SD. This value was considered consistent with the magnitude of autonomic effects reported in water-based post-exercise recovery contexts and allowed for additional variability expected under real-world training conditions (Ravier et al., |
| Randomization, allocation concealment, and blinding |
Participants were randomly allocated to a contrast heat-cold recovery group or a control group. The allocation sequence was generated before enrollment by an independent researcher who was not involved in recruitment, intervention delivery, outcome assessment, or data analysis. Randomization was stratified by club and implemented with proportional sex allocation within each club. The random sequence was generated using Research Randomizer online application with simple stratified 1:1 allocation. Randomization was conducted separately within each club to minimize club-specific effects and to achieve balanced allocation, with proportional distribution by sex within each club. For sex allocation, separate allocation lists were prepared within each club-by-sex stratum. Allocation concealment was maintained using sequentially numbered, opaque, sealed envelopes, which were opened only after eligibility confirmation, written consent, and baseline testing. Outcome assessors remained blinded to group allocation throughout physiological testing. Due to the nature of the recovery intervention, participant blinding was not feasible. To reduce detection bias, all physiological outcome assessments were performed by a blinded medical team (physiotherapists and nurses) who were unaware of group allocation, and all assessments were carried out at the same medical facility using identical environmental and organizational procedures. |
| Intervention and control conditions Contrast water group |
The recovery intervention consisted of contrast heat-cold water exposure applied after training sessions. The protocol was based on commonly described contrast-water therapy procedures used in sports and rehabilitation research and was designed to provide a meaningful thermoregulatory and vascular stimulus while remaining feasible in club-based settings. The intervention lasted 10 minutes and involved alternating exposures to warm and cold water in a 1:1 ratio. The protocol always started with warm-water exposure and ended with cold-water exposure, consistent with standard contrast water-therapy approaches aimed at recovery. This sequence is recommended to enhance tolerance of the intervention, prepare the vascular system for thermal stress, and promote vasoconstrictive responses during the final phase of exposure. The sequence consisted of five cycles of 1 minute of warm water followed by 1 minute of cold water. The water temperature was maintained at 38-40°C, a range shown to induce peripheral vasodilation without excessive thermal strain. The cold-water temperature was maintained between 13 and 15°C, a range commonly reported in the literature as sufficient to elicit vascular and sensory responses while remaining tolerable during repeated exposure. Prior to the start of the intervention period, water temperatures were measured and verified in both clubs using calibrated thermometers to establish reference values and confirm the ability to maintain target temperatures. Implementation of the protocol was facilitated by the thermostatic mixing valves installed in the shower facilities of both clubs. Exposure time was controlled using portable timers installed in the shower area. Participants were instructed to self-monitor the duration of each phase and to switch water temperature precisely every 60 seconds according to the predefined protocol. Before the intervention period, all participants received standardized instructions and a brief practical demonstration on how to correctly perform the contrast procedure and control both time and temperature. The shower sessions were self-administered by athletes in the club shower facilities after standardized instruction. Protocol fidelity was supported by coach/research-team contact, weekly adherence recording, portable timers, thermostatic shower controls, and periodic temperature and timing spot checks. Participants were instructed to complete the assigned shower as soon as possible after each scheduled training session, before leaving the club facilities and before undertaking any additional recovery modality. The time from training cessation to shower initiation was within 5 minutes. The intended exposure was whole-body showering, with participants instructed to expose the trunk and upper and lower limbs as uniformly as possible during each phase. Participants completed the assigned shower protocol in the same club shower facilities in which the intervention had been standardized. During the 4-week intervention, protocol fidelity was monitored using periodic spot checks of water temperature and phase timing. Water temperature was checked twice weekly in both clubs using calibrated thermometers, and phase duration was verified using the installed timers. Recorded temperatures remained within the prespecified ranges for warm exposure (38.6 ± 0.9°C), cold exposure (14.1 ± 0.7 °C), and thermoneutral control showers (33.3 ± 1.1°C). |
| Thermoneutral shower control |
The thermoneutral shower control condition consisted of a 10-minute shower using thermoneutral water intended to avoid eliciting marked thermoregulatory or vascular responses. Water temperature in the control condition was maintained between 32 and 34°C, a range commonly described in the literature as thermoneutral for human skin and not inducing marked vasodilation or vasoconstriction. As in the intervention group, shower duration in the control condition was controlled using timers, and participants followed standardized instructions. The use of a fixed sequence of thermal exposures, standardized temperature ranges, and controlled exposure times allowed for consistent application of both intervention and control protocols across participants and clubs, thereby reducing variability in the execution of the procedures. The recovery intervention was performed after every scheduled training session throughout the intervention period. Training frequency at both clubs typically ranged from 3 to 5 sessions per week, and the contrast heat-cold protocol was applied after each completed training session. Consequently, participants were exposed to the recovery intervention up to five times per week during the four-week intervention period. Attendance at training sessions and completion of the assigned recovery protocol were recorded weekly. Missed training sessions and omitted recovery interventions were documented, allowing for the calculation of individual compliance with the intervention protocol. As in the contrast heat-cold shower group, thermoneutral shower control sessions were self-administered in the standardized club shower facilities after scheduled training sessions, using portable timers to standardize the 10-minute duration. Participants were instructed to expose the body as uniformly as possible under the shower stream and to complete the assigned shower before leaving the club facilities. |
| Adherence monitoring and analysis populations |
The recovery protocol was performed after every scheduled training session during the 4-week intervention period. Typical training frequency was three to five sessions per week, resulting in up to five recovery exposures weekly, and attendance plus completion of the assigned recovery protocol were recorded weekly. Adherence was calculated as the percentage of completed assigned shower sessions relative to the number of scheduled eligible post-training shower sessions during the intervention. A per-protocol threshold of ≥ 75% compliance was predefined to ensure adequate exposure to the stimulus; participants not meeting this threshold were excluded from per-protocol analyses, while their data were retained for complementary intention-to-treat analyses when appropriate. |
| Standardization of training context and monitoring of training load and fatigue |
The study was conducted under natural training conditions, with athletes continuing their usual sport-specific programs prescribed by their clubs, and no study-driven modifications to training volume, intensity, or structure were imposed. To reduce confounding from intergroup differences in training exposure, both clubs implemented a comparable weekly microcycle structure consisting of approximately 90-minute primary sessions, including task-based training, sparring, general motor preparation/cross-training-type work, and grappling/wrestling technique sessions, with an optional low-intensity session on Saturday and a scheduled rest day on Sunday. Subjective internal training load was monitored using the session-RPE approach. After each training session, athletes recorded session-RPE in training diaries and reported weekly summaries to coaches, who forwarded the data to the research team. Weekly session-RPE training load was calculated as session duration in minutes multiplied by session-RPE and by the number of recorded sessions completed during that week (Haddad et al., |
| Measurement procedures and testing environment |
All assessments followed a standardized protocol in clinical rooms with ambient temperature maintained at 21-23°C and relative humidity 40-60% to minimize environmental influences on vascular and autonomic measures. The same pre-assessment restrictions were applied to PORH, HRV, and cortisol testing, i.e., participants were instructed to avoid vigorous exercise, caffeine, nicotine, alcohol, and heavy meals before testing, and compliance with these restrictions was confirmed verbally at each visit before physiological measurements began. Participants completed a resting acclimatization period before each testing session to stabilize cardiovascular parameters. Testing order was fixed across all time points to reduce procedural interactions: HRV assessment was conducted first to avoid potential carryover effects from vascular occlusion or anticipatory stress related to biological sampling, then PORH assessment, then saliva collection for cortisol, and finally subjective ratings and diary-derived outcomes. |
| Heart rate variability assessment |
Heart rate variability (HRV) was analyzed to characterize resting modulation of the autonomic nervous system. RR intervals were recorded using a Polar H10 telemetry chest strap (Polar Electro, Finland) connected via Bluetooth to the HRV Logger mobile application (Altini, version 2.6). Recordings were performed at the same time of day for each participant, within the standardized morning testing window used for physiological assessments. Participants were instructed to avoid vigorous exercise, caffeine, nicotine, alcohol, and heavy meals before testing according to the same pre-assessment restrictions applied across physiological outcomes. After arrival, participants completed a standardized resting stabilization period of 5 minutes in a supine position before HRV acquisition. RR intervals were then recorded for 5 minutes under quiet resting conditions (Malik et al., Resting autonomic modulation was evaluated using heart rate variability analysis based on RR interval recordings. RR interval data were exported as.txt files and processed in Kubios HRV Scientific software (version 4.2.0, University of Eastern Finland, Kuopio, Finland). Recordings were visually inspected and processed using the same artifact-correction settings across all time points. Recordings were excluded or repeated when there was signal loss, non-sinus rhythm, ectopic-beat clustering, or excessive artifact correction exceeding 5% of beats. Analyses were restricted to time-domain metrics selected for robustness and practical interpretability in applied settings, specifically mean heart rate (bpm), mean RR interval (ms), RMSSD (ms), lnRMSSD, and SDNN (ms). HRV was obtained under standardized resting conditions and repeated at T0, T1, and T2, with consistent procedures across time points to support longitudinal comparability. |
| Microvascular reactivity assessment (post-occlusive reactive hyperemia) |
Microvascular function was assessed using post-occlusive reactive hyperemia (PORH) under standardized resting conditions. Participants rested ≥ 10 min in a semi-recumbent position with standardized limb positioning to stabilize systemic hemodynamics and minimize prior-activity effects. Cutaneous perfusion was recorded continuously using laser Doppler flowmetry (LDF; Perimed, Perimed AB, Sweden) and expressed in perfusion units (PU); the LDF system was calibrated per manufacturer before data collection. The LDF probe was positioned on the pulp of the great toe of the examined lower limb, avoiding visible veins, calluses, wounds, bruising, or skin irritation. The toe and foot were immobilized with adhesive tape affixed to a stable support to minimize motion artefacts. Probe placement was standardized using the same anatomical site at each visit and was verified before each recording. Measurements were performed bilaterally on the right and left lower limbs, with randomized limb order and a 15-min interval between limbs to allow perfusion to return to baseline and minimize carryover from the preceding ischemic stimulus. Right- and left-limb PORH values were averaged at each time point to generate one participant-level value per PORH variable for the primary analysis. Before PORH, peripheral arterial suitability was verified by assessing arterial flow and ankle-brachial index (ABI). Doppler ultrasound (SonoScape system, linear probe 3-18 MHz) was used to evaluate flow at a standardized anatomical site with consistent insonation angle and ultrasound gel. ABI and Doppler findings were used as control measures to confirm adequate perfusion prior to proceeding with occlusion. Skin temperature was not directly monitored. Environmental standardization, acclimatization, and repeated same-site testing were used to reduce temperature-related variability. For PORH ( |
| Salivary cortisol assessment |
Salivary cortisol was assessed as an index of systemic stress/physiological load at three time points: T0 (pre-intervention), T1 (immediately post-intervention), and T2 (post-2-week washout). To reduce diurnal and day-to-day variability, saliva was collected on two consecutive mornings (Monday and Tuesday) at each time point within the same fixed morning time window, and the mean of the two values was used for analysis. Samples were collected between 07:00 and 09:00 and at approximately 30 min after habitual waking. The same clock-time window and wake-to-sampling interval were maintained as closely as possible for each participant across T0, T1, and T2. Sampling was scheduled to be consistent relative to participants’ habitual wake time (i.e., collected at a similar clock time and as comparable as feasible across time points) to limit confounding from circadian cortisol dynamics. Saliva collection was performed at Provita Medical Center during the standardized morning assessment visits. Participants were instructed to standardize pre-sampling conditions by refraining from food, caffeine, smoking/nicotine, and vigorous physical activity for ≥ 60 min before collection, and to avoid behaviors that can contaminate saliva or acutely alter readings (e.g., tooth brushing and mouthwash immediately before sampling). Immediately prior to sampling, participants rinsed their mouth with water and waited a short, consistent period before providing saliva. Samples were collected using a consistent method across all sessions (Salivette-type swab), then stored under standardized conditions (refrigerated promptly and frozen at -20°C/-80°C until analysis) to preserve hormone stability and reduce pre-analytical variability. Cortisol concentrations were quantified using a competitive ELISA with the Cortisol Saliva ELISA kit (IBL International GmbH, Hamburg, Germany; catalog no. RE52611), strictly following the manufacturer’s protocol. The assay limit of quantitation sensitivity was 0.138 nmol/L (0.005 μg/dL), with intra-assay and inter-assay coefficients of variation of 4.3% and 13.2%, respectively, according to manufacturer specifications. All samples were analyzed in duplicate, and all time-point samples from the same participant were run on the same plate/assay batch to minimize inter-assay variation. Results were reported in the kit-specified units, with consistent handling of values below the limit of detection (per manufacturer guidance) and identical processing rules applied across all participants and time points. |
| Subjective outcomes |
Perceived recovery was assessed using the Total Quality Recovery (TQR) scale at each time point (Fessi et al., |
| Statistical procedures |
All analyses were designed to quantify differential longitudinal change between groups across baseline (T0), post-intervention (T1), and wash-out (T2), while emphasizing effect magnitude and precision. The primary analysis was per-protocol, including participants with ≥ 75% compliance, with an intention-to-treat sensitivity analysis retaining all randomized participants and all available observations. Outcomes are summarized as mean ± SD by group and time point. For each endpoint, inference used linear mixed-effects models with fixed effects for Group, Time (categorical), and Group×Time, and a participant-level random intercept to account for within-subject dependence; sex and club were included as prespecified covariates where estimable, and training load/fatigue variables were evaluated in prespecified adjusted sensitivity models (e.g., intervention-period averages) to test robustness to concurrent training exposure. Model assumptions were checked using residual diagnostics, with log-transformation applied when needed for skewed outcomes (notably cortisol and selected PORH variables) and results reported consistently on the interpretable scale. Between-group effects were quantified as differences in change (ΔΔ) for T1-T0 and T2-T0 derived from the Group×Time interaction, reported with 95% CIs and two-sided p-values (p < 0.001 when applicable). Within-group changes were estimated from the same models using estimated marginal means and pairwise contrasts within each group (T1 vs T0, T2 vs T0, T2 vs T1), with multiplicity control for the three time comparisons per group. Practical relevance was addressed using standardized effects for pretest-posttest control designs (Hedges’ g for the between-group difference in change, standardized by pooled baseline SD) with 95% CIs obtained by participant-level bootstrap; within-group standardized mean changes were computed analogously for context. Figures display group means across time with SD error bars in black-and-white to facilitate direct visual comparison. Statistical analysis was conducted in R environment (R 4.5.2, R Core Team). |
|
|
| Participant flow, adherence, and outcome availability |
Sixty athletes were randomized after baseline testing, with 30 allocated to contrast heat-cold showering and 30 allocated to thermoneutral showering. All randomized participants received the allocated condition and were retained for intention-to-treat sensitivity analyses. The primary per-protocol analysis included 57 participants who achieved at least 75% compliance with the assigned shower protocol: 28 in the contrast heat-cold group and 29 in the control group. Three randomized participants were excluded from the per-protocol analysis for compliance below the prespecified threshold (contrast n = 2; control n = 1). Participant flow, per-protocol exclusions, and outcome-specific analytic samples are summarized in |
| Training-load, adherence, and wellness monitoring during the intervention |
Training-load and wellness monitoring data are reported in Fatigue scores were comparable between groups (contrast 5.51 ± 0.39; control 5.53 ± 0.46; difference -0.02, 95% CI -0.24 to 0.21; p = 0.882), and wellness scores showed no clear between-group imbalance (contrast 6.26 ± 0.48; control 6.13 ± 0.47; difference 0.13, 95% CI -0.12 to 0.38; p = 0.308). Completed assigned shower sessions were similar between groups across the 4-week intervention (contrast heat-cold shower group: 16.2 ± 1.2 sessions; thermoneutral shower control group: 16.5 ± 1.2 sessions). Mean shower-protocol adherence was also similar between groups (contrast heat-cold shower group: 81.07 ± 5.99%; thermoneutral shower control group: 82.76 ± 6.06%; difference -1.69%, 95% CI -4.89 to 1.51; p = 0.295). |
| Between-group effects for autonomic, endocrine, perceptual, and microvascular outcomes |
Descriptive statistics across T0, T1, and T2 and the primary between-group differences in change are reported in Autonomic outcomes showed the clearest post-intervention between-group difference. From T0 to T1, the contrast heat-cold group showed lower resting heart rate relative to control (ΔΔ -2.10 bpm, 95% CI -2.24 to -1.96; g -0.65; p < 0.001) and higher HRV indices, including lnRMSSD (ΔΔ 0.123 log units, 95% CI 0.108 to 0.137; g 0.74; p < 0.001), RMSSD (ΔΔ 7.97 ms, 95% CI 6.91 to 9.02; g 0.75; p < 0.001), and SDNN (ΔΔ 10.48 ms, 95% CI 6.47 to 14.49; g 0.63; p < 0.001). These effects were not maintained at T2 versus T0 for resting heart rate (ΔΔ 0.01 bpm, 95% CI -0.14 to 0.15; g 0.00; p = 0.934), lnRMSSD (ΔΔ -0.002 log units, 95% CI -0.016 to 0.012; g -0.01; p = 0.776), RMSSD (ΔΔ -0.12 ms, 95% CI -1.02 to 0.77; g -0.01; p = 0.783), or SDNN (ΔΔ 1.87 ms, 95% CI -1.90 to 5.64; g 0.11; p = 0.325). The confidence intervals for resting heart rate and lnRMSSD were checked against the observed change-score variability and reflected low participant-level variability in T0-to-T1 change scores (heart-rate Δ SD: 0.32 bpm in contrast and 0.18 bpm in control; lnRMSSD Δ SD: 0.035 and 0.019 log units, respectively), whereas SDNN showed larger change-score variability (6.90 and 7.98 ms), explaining its wider confidence interval. Subjective recovery showed a post-intervention between-group effect in the same temporal direction as the autonomic outcomes. TQR increased from 13.4 ± 0.5 to 15.9 ± 0.5 in the control group and from 13.1 ± 1.0 to 16.2 ± 0.9 in the contrast heat-cold group, corresponding to a T0-to-T1 ΔΔ of 0.61 TQR points (95% CI 0.27 to 0.95; g 0.80; p < 0.001). The T2-to-T0 between-group contrast was smaller and not statistically clear (ΔΔ 0.12 TQR points, 95% CI -0.37 to 0.62; g 0.16; p = 0.622), indicating that the post-intervention perceptual effect was not retained after wash-out. Morning salivary cortisol did not show a statistically clear intervention-specific change. The T0-to-T1 ratio of ratios was 1.05 (95% CI 0.99 to 1.11; g 0.43; p = 0.132), and the T2-to-T0 ratio of ratios was 1.00 (95% CI 0.93 to 1.07; g -0.02; p = 0.962). PORH-derived microvascular outcomes are summarized in Intention-to-treat sensitivity estimates are provided for every endpoint and contrast in |
|
|
In this randomized field trial in trained combat sport athletes, a four-week contrast heat-cold shower protocol showed short-term relative improvements compared with thermoneutral showering in resting autonomic indices (lower resting heart rate and higher vagally mediated HRV) and perceived recovery. These relative improvements were not maintained after the two-week wash-out, indicating predominantly transient rather than persistent group-level responses. In contrast, morning salivary cortisol did not show a consistent intervention-specific signal, and microvascular reactivity assessed via PORH improved over time in both groups without detectable between-group separation, suggesting that several observed changes likely reflected time- or training-related influences rather than a unique physiological effect of contrast showers. Autonomic outcomes showed the most coherent intervention pattern, with the contrast group demonstrating a post-intervention shift consistent with greater parasympathetic modulation that was not retained after wash-out (Laborde et al., Subjective recovery (TQR) improved after the intervention period, with a clearer post-intervention advantage for the contrast group, but the effect did not persist following wash-out, mirroring the time course observed for autonomic outcomes (Kenttä and Hassmén, Endocrine responses, assessed via averaged morning salivary cortisol, did not display a clear intervention-specific pattern, and within-group fluctuations were modest and bidirectional across time points (Cevada et al., Microvascular reactivity assessed with PORH showed improvements over time in both groups, but without between-group separation, indicating that the contrast protocol did not produce a detectable incremental effect on the PORH-derived endpoints used here (Lenasi and Štrucl, Several limitations should be considered when interpreting these results and planning future work. The sample included a small number of women, which limits sex-specific interpretation. Sex was reported descriptively but was not included as a covariate or effect modifier because the small female subsample would have produced sparse group-by-sex cells and unstable estimates. Therefore, the findings should be interpreted primarily as group-level effects in the combined combat-sport sample rather than as evidence of equivalent responses across sexes. Menstrual-cycle phase and hormonal contraceptive status were not standardized, which further limits interpretation of HRV, cortisol, and vascular responses in female athletes. Future studies should recruit sufficient numbers of women to permit sex-specific analyses and should record or standardize menstrual-cycle phase and contraceptive status where feasible. Training continued in real-world conditions, and while this enhances ecological validity, variability in training load, life stress, sleep, and unmeasured recovery behaviors may have influenced endocrine, perceptual, autonomic, and microvascular endpoints (Sinnott-O’Connor et al., From a practical perspective, these findings should be interpreted as evidence of short-term relative changes in resting autonomic and perceptual recovery indicators, not as proof of durable recovery adaptation or performance enhancement. Because the broader evidence base shows heterogeneity and meaningful placebo contributions for water-based recovery methods, implementation should prioritize individual preference, tolerability, and consistency while avoiding overinterpretation of benefits as guaranteed physiological adaptations. In combat-sport environments with dense technical, sparring, and conditioning schedules, contrast heat-cold showering may be considered only as a short-term recovery-support strategy when the practical objective is perceived restoration or resting autonomic recovery. However, because this study did not measure sport performance, neuromuscular adaptation, or competition outcomes, no conclusion can be made about performance transfer. Practitioners should therefore integrate contrast showering within a broader recovery framework that includes sleep, nutrition, training-load management, and individualized monitoring rather than treating it as a standalone recovery solution. |
|
|
In the current sample of trained combat sport athletes, contrast heat-cold showering showed short-term relative improvements versus thermoneutral showering in resting autonomic indices and perceived recovery after four weeks. These effects were not maintained after the two-week wash-out. No clear intervention-specific effects were observed for morning salivary cortisol or PORH-derived cutaneous microvascular outcomes. Because participants were not blinded, training continued under real-world conditions, the comparator was an active thermoneutral shower, and no performance outcomes were measured, the findings should be interpreted as transient autonomic and perceptual responses rather than definitive evidence of durable multisystem recovery adaptation or performance benefit. |
| ACKNOWLEDGEMENTS |
The authors report no actual or potential conflicts of interest. While the datasets generated and analyzed in this study are not publicly available, they can be obtained from the corresponding author upon request. All experimental procedures were conducted in compliance with the relevant legal and ethical standards of the country where the study was carried out. The authors declare that no Generative AI or AI-assisted technologies were used in the writing of this manuscript. |
| AUTHOR BIOGRAPHY |
|
| REFERENCES |
|